A lab-stage mRNA vaccine targeting ticks may offer protection against Lyme and other tick-borne diseases
- Written by Andaleeb Sajid, Staff Scientist, National Institutes of Health
As the rate of tick-borne diseases rises, vaccines that stop ticks in their tracks could be an essential preventive tool.rbkomar/Moment via Getty ImagesThe Research Brief is a short take about interesting academic work.
The big idea
A new laboratory-stage mRNA vaccine that teaches the immune system to recognize the saliva from tick bites could...

















